Clinical Trial

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this registry is to gain more insight on the clinical use of the Occlutech perimembranous VSD occluder.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-07-25; most recent amendment 2026-01-14.
Status change: Recruiting → Active, Not Recruiting 2024-02-13
Trial Details
NCT Number NCT04034498
Lead Sponsor Occlutech International AB
Conditions Perimembranous Ventricular Septal Defect
Enrollment 50 participants
Start Date 2019-07-07
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-16